Please Wait
Applying Filters...
Menu
Xls
2D Structure
Also known as: Fluzoparib, 1358715-18-0, Fuzuopali, Shr-3162, Shr3162, Twf0ml1ck8
Molecular Formula
C22H16F4N6O2
Molecular Weight
472.4  g/mol
InChI Key
XJGXCBHXFWBOTN-UHFFFAOYSA-N
FDA UNII
TWF0ML1CK8

FLUZOPARIB is a small molecule drug with a maximum clinical trial phase of III (across all indications) and has 21 investigational indications.
1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
4-[[4-fluoro-3-[2-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazine-7-carbonyl]phenyl]methyl]-2H-phthalazin-1-one
2.1.2 InChI
InChI=1S/C22H16F4N6O2/c23-16-6-5-12(10-17-13-3-1-2-4-14(13)19(33)29-28-17)9-15(16)20(34)31-7-8-32-18(11-31)27-21(30-32)22(24,25)26/h1-6,9H,7-8,10-11H2,(H,29,33)
2.1.3 InChI Key
XJGXCBHXFWBOTN-UHFFFAOYSA-N
2.2 Other Identifiers
2.2.1 UNII
TWF0ML1CK8
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Fluzoparib

2. 4-((4-fluoro-3-(2-(trifluoromethyl)-6,8-dihydro-5h-(1,2,4)triazolo(1,5-a)pyrazine-7-carbonyl)phenyl)methyl)-2h-phthalazin-1-one

3. Shr3162

2.3.2 Depositor-Supplied Synonyms

1. Fluzoparib

2. 1358715-18-0

3. Fuzuopali

4. Shr-3162

5. Shr3162

6. Twf0ml1ck8

7. 4-[[4-fluoro-3-[2-(trifluoromethyl)-6,8-dihydro-5h-[1,2,4]triazolo[1,5-a]pyrazine-7-carbonyl]phenyl]methyl]-2h-phthalazin-1-one

8. Hs10160

9. Hs-10160

10. 1(2h)-phthalazinone, 4-((3-((5,6-dihydro-2-(trifluoromethyl)(1,2,4)triazolo(1,5-a)pyrazin-7(8h)-yl)carbonyl)-4-fluorophenyl)methyl)-

11. 4-((3-((5,6-dihydro-2-(trifluoromethyl)(1,2,4)triazolo(1,5-a)pyrazin-7(8h)-yl)carbonyl)-4-fluorophenyl)methyl)-1(2h)-phthalazinone

12. Airuiyi

13. 4-((4-fluoro-3-(2-(trifluoromethyl)-6,8-dihydro-5h-(1,2,4)triazolo(1,5-a)pyrazine-7-carbonyl)phenyl)methyl)-2h-phthalazin-1-one

14. Refchem:141090

15. 4-((4-fluoro-3-(2-(trifluoromethyl)-5h,6h,7h,8h-(1,2,4)triazolo(1,5-a)pyrazine-7-carbonyl)phenyl)methyl)-1,2-dihydrophthalazin-1-one

16. Unii-twf0ml1ck8

17. Fluzoparib (shr-3162)

18. 4-(4-fluoro-3-(2-(trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyrazine-7-carbonyl)benzyl)phthalazin-1(2h)-one

19. Fluzoparib?

20. 25i

21. Fuzuloparib [inn]

22. Fluzoparib [who-dd]

23. Orb1298619

24. Chembl3930624

25. Schembl10025553

26. Schembl29361923

27. Schembl30641389

28. Gtpl13763

29. C22h16f4n6o2

30. Dtxsid801374052

31. Glxc-23874

32. Hms5086g20

33. Ex-a8180

34. Shr3162; Fuzuopali; Fuzuloparibum

35. S9712

36. Ms-28738

37. Hy-114778

38. Cs-0064303

39. G17612

2.4 Create Date
2012-03-05
3 Chemical and Physical Properties
Molecular Weight 472.4 g/mol
Molecular Formula C22H16F4N6O2
XLogP32.4
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count9
Rotatable Bond Count3
Exact Mass Da
Monoisotopic Mass Da
Topological Polar Surface Area92.5
Heavy Atom Count34
Formal Charge0
Complexity839
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Treatment of prostate cancer



5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Poly(ADP-ribose) Polymerase Inhibitors

Chemicals and drugs that inhibit the action of POLY(ADP-RIBOSE)POLYMERASES.